drugset / Trial / NCT02923336

Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics

NCT02923336

Unknown 10 enrolled ALDO TORRE DELGADILLO
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to evaluate the influence of non betablockers in gastrointestinal motility (transit time) in patients with liver cirrhosis.

Timeline

Start
2015-05
Primary completion
2019-01
Completion
2021-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 80 mg

Indications